Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 10(1): 6740, 2020 04 21.
Article in English | MEDLINE | ID: mdl-32317718

ABSTRACT

To protect the audiosensory organ from tissue damage from the immune system, the inner ear is separated from the circulating immune system by the blood-labyrinth barrier, which was previously considered an immune-privileged site. Recent studies have shown that macrophages are distributed in the cochlea, especially in the spiral ligament, spiral ganglion, and stria vascularis; however, the direct pathogen defence mechanism used by audiosensory receptor hair cells (HCs) has remained obscure. Here, we show that HCs are protected from pathogens by surrounding accessory supporting cells (SCs) and greater epithelial ridge (GER or Kölliker's organ) cells (GERCs). In isolated murine cochlear sensory epithelium, we established Theiler's murine encephalomyelitis virus, which infected the SCs and GERCs, but very few HCs. The virus-infected SCs produced interferon (IFN)-α/ß, and the viruses efficiently infected the HCs in the IFN-α/ß receptor-null sensory epithelium. Interestingly, the virus-infected SCs and GERCs expressed macrophage marker proteins and were eliminated from the cell layer by cell detachment. Moreover, lipopolysaccharide induced phagocytosis of the SCs without cell detachment, and the SCs phagocytosed the bacteria. These results reveal that SCs function as macrophage-like cells, protect adjacent HCs from pathogens, and provide a novel anti-infection inner ear immune system.


Subject(s)
Hair Cells, Auditory, Inner/physiology , Hair Cells, Auditory, Outer/physiology , Labyrinth Supporting Cells/immunology , Macrophages/immunology , Spiral Ganglion/physiology , Stria Vascularis/physiology , Animals , Animals, Newborn , Escherichia coli/immunology , Hair Cells, Auditory, Inner/cytology , Hair Cells, Auditory, Outer/cytology , Immunity, Innate , Interferon-alpha/biosynthesis , Interferon-alpha/immunology , Interferon-beta/biosynthesis , Interferon-beta/immunology , Labyrinth Supporting Cells/cytology , Labyrinth Supporting Cells/drug effects , Labyrinth Supporting Cells/virology , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/virology , Mice , Mice, Inbred ICR , Organ Culture Techniques , Phagocytosis/drug effects , Saccharomyces cerevisiae/immunology , Spiral Ganglion/cytology , Stria Vascularis/cytology , Theilovirus/growth & development , Theilovirus/pathogenicity
2.
Hear Res ; 277(1-2): 28-36, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21530627

ABSTRACT

Gene-based therapeutics are being developed as novel treatments for genetic hearing loss. One roadblock to effective gene therapy is the identification of vectors which will safely deliver therapeutics to targeted cells. The cellular heterogeneity that exists within the cochlea makes viral tropism a vital consideration for effective inner ear gene therapy. There are compelling reasons to identify a viral vector with tropism for organ of Corti supporting cells. Supporting cells are the primary expression site of connexin 26 gap junction proteins that are mutated in the most common form of congenital genetic deafness (DFNB1). Supporting cells are also primary targets for inducing hair cell regeneration. Since many genetic forms of deafness are congenital it is necessary to administer gene transfer-based therapeutics prior to the onset of significant hearing loss. We have used transuterine microinjection of the fetal murine otocyst to investigate viral tropism in the developing inner ear. For the first time we have characterized viral tropism for supporting cells following in utero delivery to their progenitors. We report the inner ear tropism and potential ototoxicity of three previously untested vectors: early-generation adenovirus (Ad5.CMV.GFP), advanced-generation adenovirus (Adf.11D) and bovine adeno-associated virus (BAAV.CMV.GFP). Adenovirus showed robust tropism for organ of Corti supporting cells throughout the cochlea but induced increased ABR thresholds indicating ototoxicity. BAAV also showed tropism for organ of Corti supporting cells, with preferential transduction toward the cochlear apex. Additionally, BAAV readily transduced spiral ganglion neurons. Importantly, the BAAV-injected ears exhibited normal hearing at 5 weeks of age when compared to non-injected ears. Our results support the use of BAAV for safe and efficient targeting of supporting cell progenitors in the developing murine inner ear.


Subject(s)
Adenoviridae/genetics , Deafness/therapy , Dependovirus/genetics , Gene Transfer Techniques , Genetic Therapy/methods , Genetic Vectors , Labyrinth Supporting Cells/virology , Organ of Corti/virology , Viral Tropism , Acoustic Stimulation , Animals , Audiometry, Pure-Tone , Auditory Threshold , Deafness/genetics , Deafness/physiopathology , Evoked Potentials, Auditory, Brain Stem , Gene Transfer Techniques/adverse effects , Genetic Therapy/adverse effects , Genetic Vectors/adverse effects , Gestational Age , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Labyrinth Supporting Cells/metabolism , Mice , Mice, Inbred BALB C , Microinjections , Microscopy, Fluorescence , Organ of Corti/embryology , Organ of Corti/metabolism , Organ of Corti/physiopathology , Stem Cells/virology , Transduction, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL